Tehran University of Medical Sciences

Science Communicator Platform

Share By
Novel Imidazo[1,2-A]Pyridine-Based Α-Glucosidase Inhibitors: Synthesis, Biological Evaluations, and Computational Studies Publisher Pubmed

Summary: Could a new molecule block a diabetes-related enzyme? Compound 10s strongly blocked alpha-glucosidase in lab tests; human benefit is untested. #DrugDiscovery #Diabetes

Norouzbahari M ; Emamgholipour Z ; Peytam F ; Saadattalab T ; Bayati B ; Gulcan H O ; Mojtabavi S ; Ghasemi F ; Bijanzadeh H R ; Firoozpour L ; Foroumadi A
Authors

Source: Scientific Reports Published:2026


Abstract

In an attempt to identify novel α‑glucosidase inhibitors, a new series of substituted imidazo[1,2‑a]pyridine derivatives (10a–10ab) was designed, synthesized, and evaluated for their inhibitory activities. All compounds exhibited potent inhibition, with IC50 values ranging from 12.01 to 93.01 µM, significantly better than acarbose IC50 = 750.02 µM). SAR analysis highlighted the critical role of para‑substitution on the benzamide ring, especially methoxy groups. The most potent compound, 10s (IC50 = 12.01 µM), acted as a competitive inhibitor (Ki = 21 µM) with no α‑amylase inhibition, indicating high selectivity. It was non‑cytotoxic up to 100 µM. Circular dichroism, fluorescence spectroscopy, and thermodynamic analysis revealed strong ligand–enzyme interactions mainly driven by hydrophobic forces. Molecular docking and 200 ns MD simulations, including MM‑GBSA calculations, supported stable binding of 10s within the active site. Collectively, these results introduce imidazo[1,2-a]pyridine derivative 10s as a promising lead compound for the development of novel α-glucosidase inhibitors in further studies. © The Author(s) 2026.
Related Docs
View other Related Docs
1. Synthesis, Α-Glucosidase Inhibitory Activity and Docking Studies of Novel Ethyl 1,2,3-Triazol-4-Ylmethylthio-5,6-Diphenylpyridazine-4-Carboxylate Derivatives, BMC Chemistry (2023)
2. Design and Synthesis of Novel Quinoline-Piperazines Fused to a Phenylhydrazinecarbothioamide Scaffold As Promising Α-Glucosidase Inhibitors With Anti-Diabetic Potential, Future Medicinal Chemistry (2025)
3. Quinoline-Thiosemicarbazone-1,2,3-Triazole-Acetamide Derivatives As New Potent Α-Glucosidase Inhibitors, Scientific Reports (2024)
Experts (# of related papers)
View all Related Experts
Mohammad Ali Faramarzi (17)
Somayeh Mojtabavi (17)
Novel Imidazo[1,2-A]Pyridine-Based Α-Glucosidase Inhibitors: Synthesis, Biological Evaluations, and Computational Studies
Other Related Docs
4. Cyanoacetohydrazide Linked to 1,2,3-Triazole Derivatives: A New Class of Α-Glucosidase Inhibitors, Scientific Reports (2022)
5. Design of New Α-Glucosidase Inhibitors Based on the Bis-4-Hydroxycoumarin Skeleton: Synthesis, Evaluation, and in Silico Studies, Scientific Reports (2024)
6. Synthesis and Evaluation of 6-Ethoxy-2-Mercaptobenzothiazole Scaffolds As Potential Α-Glucosidase Inhibitors, ChemistrySelect (2022)
7. Novel N′-Substituted Benzylidene Benzohydrazides Linked to 1,2,3-Triazoles: Potent Α-Glucosidase Inhibitors, Scientific Reports (2023)
8. Novel Pyrido[2,3-D]Pyrimidine Linked to Benzyloxy-Phenyl and Benzyl-Triazole Hybrids As Alpha-Glucosidase Inhibitors: Synthesis, in Vitro Evaluation, and in Silico Studies, Journal of Molecular Structure (2025)
9. An Efficient and Targeted Synthetic Approach Towards New Highly Substituted 6-Amino-Pyrazolo[1,5-A]Pyrimidines With Α-Glucosidase Inhibitory Activity, Scientific Reports (2020)
10. Design, Synthesis, and Evaluation of Novel Substituted Imidazo[1,2-C]Quinazoline Derivatives As Potential Α-Glucosidase Inhibitors With Bioactivity and Molecular Docking Insights, Scientific Reports (2024)
11. Design, Synthesis, and in Silico Studies of Quinoline-Based-Benzo[D]Imidazole Bearing Different Acetamide Derivatives As Potent Α-Glucosidase Inhibitors, Scientific Reports (2022)
12. Design and Synthesis of Novel Quinazolinone-Pyrazole Derivatives As Potential Α-Glucosidase Inhibitors: Structure-Activity Relationship, Molecular Modeling and Kinetic Study, Bioorganic Chemistry (2021)
13. Identification of Novel Triazolopyrimidines As Potent Α-Glucosidase Inhibitor Through Design, Synthesis, Biological Evaluations, and Computational Analysis, Scientific Reports (2025)
14. New Coumarin–Chalcone–Triazole Hybrids As Promising Anti-Diabetic Agents: From Molecular Design to in Vivo Validation, RSC Advances (2025)
15. Design, Synthesis, in Vitro Anti-Α-Glucosidase Evaluations, and Computational Studies of New Phthalimide-Phenoxy-1,2,3-Triazole-N-Phenyl (Or Benzyl) Acetamides As Potential Anti-Diabetic Agents, Scientific Reports (2023)
16. Design, Synthesis, Molecular Docking, and in Vitro Α-Glucosidase Inhibitory Activities of Novel 3-Amino-2,4-Diarylbenzo[4,5]Imidazo[1,2-A]Pyrimidines Against Yeast and Rat Α-Glucosidase, Scientific Reports (2021)
17. Quinazolinone-1,2,3-Triazole-Acetamide Conjugates As Potent Α-Glucosidase Inhibitors: Synthesis, Enzyme Inhibition, Kinetic Analysis, and Molecular Docking Study, RSC Medicinal Chemistry (2023)
18. Novel Diazen-Bis(Phenoxy-1,2,3-Triazole-N-Phenylacetamide) Derivatives As Potent Anti-Cholinesterase, Anti-Α-Glycosidase and Anti-Α-Amylase Agents: In Vitro and in Silico Evaluations, Journal of Molecular Structure (2025)
19. Synthesis and Structure–Activity Relationship Studies of Benzimidazole-Thioquinoline Derivatives As Α-Glucosidase Inhibitors, Scientific Reports (2023)
20. Novel Diazene-Tri(Phenoxy-1,2,3-Triazole-Acetamide) Derivatives As Potent Α-Glucosidase Inhibitors: Synthesis, Biological Evaluation, and in Silico Studies, RSC Advances (2026)